Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeuroOne Medical Technologies Corporation - Common Stock (NQ:NMTC)

0.7357 +0.0034 (+0.46%)
Streaming Delayed Price Updated: 3:09 PM EST, Nov 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about NeuroOne Medical Technologies Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >
Nasdaq's Lifeline: NeuroOne Medical Technologies Secures 180-Day Extension Amidst Delisting Fears
November 5, 2025 – NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) has been granted a crucial 180-day extension by Nasdaq, providing a temporary reprieve from potential delisting. This... 
Via MarketMinute
Wondering what's happening in today's after-hours session?
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
NeuroOne Q3 Revenue Jumps 105 Percent
Via The Motley Fool
Earnings Scheduled For August 14, 2025
 
Via Benzinga
Earnings Scheduled For February 12, 2025
 
Via Benzinga
NeuroOne (NMTC) Q3 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings Intellectual Property
NeuroOne Medical Technologies (NASDAQ:NMTC) Reports Mixed Q3 2025 Earnings with Strong EPS Beat and 7% Pre-Market Surge
NeuroOne Medical Technologies reports mixed Q3 2025 earnings, missing revenue estimates but beating EPS forecasts. Strong gross margins and an $8.2M capital raise boost investor confidence, driving a... 
Via Chartmill
NeuroOne Revenue Jumps 105 Percent in Q3
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
This Okta Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
EXCLUSIVE: NeuroOne Submits FDA Marketing Application For OneRF Trigeminal Nerve Ablation System For Facial Pain
NeuroOne submits FDA filing early for trigeminal nerve ablation using its OneRF system as the facial pain market sees projected growth to $416 million by 2030. 
Via Benzinga
Which stocks are experiencing notable movement on Friday?
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
Earnings Scheduled For May 13, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet
 
Via Benzinga
Which stocks are gapping on Friday?
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday. 
Via Chartmill
Friday's pre-market session: top gainers and losers
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
Dow Tumbles 1,100 Points; US Economy Adds 228,000 Jobs In March
 
Via Benzinga
Topics Economy Stocks
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
US Stocks Likely To Open Lower After The Worst Selloff Since 2020: Tariff Announcement Was '100% Smoot Hawley Disguised As Thoughtful Policy,' Says Expert
U.S. stock futures continued to decline on Friday after a bloodbath on Thursday following the introduction of Donald Trump's tariffs. 
Via Benzinga
Topics Government
Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday
 
Via Benzinga
What's going on in today's after hours session
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Earnings Scheduled For December 17, 2024
 
Via Benzinga
NMTC Stock Earnings: NeuroOne Medical Tech Meets EPS, Misses Revenue for Q3 2024
NMTC stock results show that NeuroOne Medical Tech met analyst estimates for earnings per share but missed on revenue for the third quarter of 2024. 
Via InvestorPlace
The 3 Best Neuroscience Biotech Stocks to Buy Now
Given the high bar to developing good neuroscience drugs, firms that do so will likely succeed. Here are three top biotech stocks to buy now. 
Via InvestorPlace
3 Neurotech Stocks Bridging Mind and Machine
These neurotech stocks stand at the cutting edge of healthcare, but early entrants in new fields tend to be long-term winners. 
Via InvestorPlace
NMTC Stock Earnings: NeuroOne Medical Tech Misses EPS, Misses Revenue for Q2 2024
NMTC stock results show that NeuroOne Medical Tech missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.